OncoMed Pharmaceuticals Announces Proposed Public Offering of Common Stock
17 août 2016 16h07 HE
|
OncoMed Pharmaceuticals, Inc.
REDWOOD CITY, Calif., Aug. 17, 2016 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED), a clinical-stage company developing novel anti-cancer stem cell and immuno-oncology...
OncoMed Pharmaceuticals Reports Second Quarter 2016 Financial Results
09 août 2016 16h05 HE
|
OncoMed Pharmaceuticals, Inc.
OncoMed Management to Host Conference Call/Webcast this Afternoon at 4:30 p.m. ET/1:30 p.m. PTREDWOOD CITY, Calif., Aug. 09, 2016 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc....
OncoMed Pharmaceuticals to Report Financial Results for the Second Quarter 2016 on Tuesday, August 9, 2016
03 août 2016 08h30 HE
|
OncoMed Pharmaceuticals, Inc.
REDWOOD CITY, Calif., Aug. 03, 2016 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED), a clinical development-stage biopharmaceutical company focused on discovering and developing...
OncoMed Management to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference
07 juil. 2016 17h04 HE
|
OncoMed Pharmaceuticals, Inc.
REDWOOD CITY, Calif., July 07, 2016 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED) a clinical development-stage biopharmaceutical company focused on discovering and developing novel...
OncoMed Management to Present at Two Upcoming Investment Conferences
06 juin 2016 08h00 HE
|
OncoMed Pharmaceuticals, Inc.
REDWOOD CITY, Calif., June 06, 2016 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED) a clinical development-stage biopharmaceutical company focused on discovering and developing...
OncoMed Presents Phase 1b Data for First-in-Class Treatments in Ovarian, Breast and Lung Cancer at the 2016 ASCO Annual Meeting
05 juin 2016 09h00 HE
|
OncoMed Pharmaceuticals, Inc.
First Presentation of Combination Data for Wnt Inhibitors, Ipafricept and Vantictumab Updated Data for Demcizumab and Tarextumab Also Presented CHICAGO and REDWOOD CITY, Calif., June 05, 2016 ...
OncoMed Pharmaceuticals Announces First Quarter 2016 Financial Results
05 mai 2016 16h04 HE
|
OncoMed Pharmaceuticals, Inc.
OncoMed Management to Host Conference Call/Webcast this Afternoon at 4:30 p.m. ET/1:30 p.m. PT Highlights AACR Presentations - Including Novel GITRL-Fc Candidate Clinical Data on Vantictumab,...
OncoMed Pharmaceuticals to Report Financial Results for the First Quarter 2016 on Thursday, May 5, 2016
29 avr. 2016 08h30 HE
|
OncoMed Pharmaceuticals, Inc.
REDWOOD CITY, Calif., April 29, 2016 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED), a clinical development-stage biopharmaceutical company focused on discovering and developing...
OncoMed Announces Clinical Data to be Presented at the 2016 ASCO Annual Meeting
21 avr. 2016 16h26 HE
|
OncoMed Pharmaceuticals, Inc.
REDWOOD CITY, Calif., April 21, 2016 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals Inc. (NASDAQ:OMED) announced today it will present data from several clinical programs at the upcoming American...
OncoMed Presents Biomarker Research for Two Clinical Programs and Demcizumab Mechanism Data at the AACR Annual Meeting 2016
20 avr. 2016 08h30 HE
|
OncoMed Pharmaceuticals, Inc.
REDWOOD CITY, Calif., April 20, 2016 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals Inc. (NASDAQ:OMED), presented new biomarker research associated with its clinical programs for anti-RSPO3...